Special Announcement
Symphogen will host a conference call today (Thursday 6 September 2012) to discuss the announcement at 11:30 CET/ 10:30 BST.
Kirsten Drejer, Symphogen’s Chief Executive Officer, will host the call to discuss the licence agreement with Merck KGaA for Sym004, followed by a Q&A session. The call will be conducted in English. Please use the following dial-in details:
Denmark: 327 276 25
International: +44 (0) 1452 555 566
Please quote the following Conference ID: 28172177
An accompanying presentation will be released on Symphogen’s website and available for download just before the start of the call and can be accessed via www.symphogen.com
Seven day replay dial-in details:
Tel: +44 (0)1452 550 000
Conference ID: 28172177
